Facebook Linkedin RSS Twitter Youtube
Home 2024

Pfizer

Small-Molecule “Unsilencers” Show Promise against Angelman Syndrome
Drug Discovery

Small-Molecule “Unsilencers” Show Promise against Angelman Syndrome

Characterizing AAV Charge Heterogeneity Using High-Resolution icIEF Fractionation with LC-MS Analysis
Bioprocessing

Characterizing AAV Charge Heterogeneity Using High-Resolution icIEF Fractionation with LC-MS Analysis

Bertozzi’s TwoStep Therapeutics to Target Solid Tumors With Engineered Peptide Drug Delivery Vehicle
Cancer

Bertozzi’s TwoStep Therapeutics to Target Solid Tumors With Engineered Peptide Drug Delivery Vehicle

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GEN Edge

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

Top 10 Best Selling Drugs
A-Lists

Top 10 Best Selling Drugs

Entos Expands In-House Manufacturing with GMP Facility
Bioprocessing

Entos Expands In-House Manufacturing with GMP Facility

Mitigating Risks in Oligonucleotide Therapeutic Development
Sponsored

Mitigating Risks in Oligonucleotide Therapeutic Development

Boy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II Trial
Drug Discovery

Boy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II Trial

NIIMBL Backs Bioprocess Tech and Training Innovation in Funding Round
Bioprocessing

NIIMBL Backs Bioprocess Tech and Training Innovation in Funding Round

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
Drug Discovery

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B

123...7Page 1 of 7
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.